Delivery Order SPE2DB20D1109-SPE2DB23FN52M
Award Date 2/10/23
Potential Completion Date 2/13/23
Potential Value $1.8K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,100.22 firm fixed-price delivery order is for the supply of HAVRIX 1,440 UNIT/ML SYRINGEML, a vaccine product. The contract has an ultimate completion date of January 31, 2023 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite...
- This federal contract award, valued at $6,790.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HAVRIX 1,440 UNIT/ML syringes, a vaccine product, and has an ultimate completion date of January 10, 2023. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. Amerisourcebergen, the prime contractor, has a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,769.15 firm fixed-price delivery order is for the supply of HAVRIX 1,440 UNIT/ML SYRINGEML, which are likely vaccines or other medical supplies. The contract has an ultimate completion date of January 13, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is between the Defense Logistics Agency (DLA) and AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,905.50, is for the delivery of HAVRIX 1,440 UNIT/ML SYRINGEML. It is a firm fixed-price delivery order that runs through February 26, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,912.82 firm fixed-price delivery order is for HAVRIX 1,440 UNIT/ML SYRINGEML, a vaccine product. The contract has a period of performance through March 2025 and does not include a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,048.80 firm fixed-price delivery order is for the supply of HAVRIX 720 UNIT/0.5 ML SYRINGE 0.5ML, a vaccine product. The award has an ultimate completion date of February 6, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,908.55 firm fixed-price contract is for the supply of HAVRIX 1,440 UNIT/ML SYRINGE medication, with a completion date of June 22, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award, valued at $1,725.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the provision of HAVRIX 1,440 UNIT/ML SYRINGEML, a medical vaccine product. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,800.70 firm fixed-price delivery order is for the supply of HAVRIX 1,440 unit/mL syringes. This award is a part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,732.50 firm fixed-price delivery order is for the supply of HAVRIX 720 UNIT/0.5 ML syringes. The contract has an ultimate completion date of October 2, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...